1-4 of 4
Debra Irwin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Productivity Loss and Indirect Costs Among Non-Hodgkin Lymphoma Patients and Their Caregivers

Keri Yang, Sizhu Liu, Debra Irwin, Elizabeth Packnett, Carolyn R. Lew, Virginia Noxon, Boxiong Tang, Asher Chanan-Khan
Journal: Blood
Blood (2021) 138 (Supplement 1): 4009.
https://doi.org/10.1182/blood-2021-148443
Published: 2021
Journal Articles

Real-World Healthcare Resource Utilization in Patients with Indolent Non-Hodgkin's Lymphoma: Differences between Patients Treated First-Line with Ibrutinib or Bendamustine + Rituximab

Debra Irwin, Lu Zhang, ScD, Kathleen Wilson, MPH, Gerard Hoehn, PhD, Erika Szabo, Boxiong Tang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3549.
https://doi.org/10.1182/blood-2018-99-113093
Published: 2018
Journal Articles

Real-World Healthcare Resource Utilization in Patients with Chronic Lymphocytic Lymphoma: Differences between Patients Treated with Ibrutinib or Bendamustine + Rituximab

Debra Irwin, Lu Zhang, ScD, Kathleen Wilson, MPH, Gerard Hoehn, PhD, Erika Szabo, Boxiong Tang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3548.
https://doi.org/10.1182/blood-2018-99-112626
Published: 2018
Journal Articles

Length of Stay for Hospitalized Patients Treated with Ibrutinib or Bendamustine First-Line Therapy for Treatment of Chronic Lymphocytic Leukemia

Debra Irwin, Erika Szabo, Ashutosh Pathak, Boxiong Tang, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5618.
https://doi.org/10.1182/blood.V130.Suppl_1.5618.5618
Published: 2017